Boehringer Ingelheim Animal Health España, S.A.U.

Company Premium

La división veterinaria de Boehringer Ingelheim España inició su actividad en 1971 aportando soluciones innovadoras para prevenir, curar y tratar las enfermedades de los animales. En el caso del porcino (43% del total de la facturación), nuestro principal foco consiste en la producción de vacunas para mejorar el bienestar de los animales y así trabajar en la obtención de un futuro más saludable para todos.

Send message
Vaccination

How PCV2 vaccines work

19-Jan-2016

Despite not having a consistent post-vaccination serological reaction, vaccinated animals behave differently from unvaccinated animals under field conditions.The article explains why vaccines offer protection.

Serum and oral fluid PRRSV qRT-PCR results by post-inoculation week

Oral fluids in PRRS diagnosis

29-May-2015

Diagnosis in oral fluids is indicated for the control of replacements on arrival and after the adaptation process, and of the different production batches, especially risk subpopulations such as animals with a slow growth rate.

PRRS

Transmission routes, control and prevention of PRRS

30-Jan-2015

PRRS virus infection can be considered common in areas of high pig density and, in such cases, the idea that biosecurity and can do little is widespread. However, proper biosecurity measures must be implemented in order to prevent the introduction of new strains.

Contact:

Contact us using the following form.